Mark Spigelman

4.0k total citations
63 papers, 2.2k citations indexed

About

Mark Spigelman is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Mark Spigelman has authored 63 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 22 papers in Epidemiology and 17 papers in Surgery. Recurrent topics in Mark Spigelman's work include Tuberculosis Research and Epidemiology (22 papers), Mycobacterium research and diagnosis (21 papers) and Infectious Diseases and Tuberculosis (13 papers). Mark Spigelman is often cited by papers focused on Tuberculosis Research and Epidemiology (22 papers), Mycobacterium research and diagnosis (21 papers) and Infectious Diseases and Tuberculosis (13 papers). Mark Spigelman collaborates with scholars based in United Kingdom, Israel and United States. Mark Spigelman's co-authors include Helen D. Donoghue, I. Rylski, Charles L. Greenblatt, Eshetu Lemma, Gila Kahila Bar‐Gal, David E. Minnikin, Oona Y.-C. Lee, John Holton, Gurdyal S. Besra and Bruce M. Rothschild and has published in prestigious journals such as The Lancet, Nature Communications and PLoS ONE.

In The Last Decade

Mark Spigelman

62 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Spigelman United Kingdom 24 1.1k 826 581 574 484 63 2.2k
Gila Kahila Bar‐Gal Israel 21 614 0.6× 432 0.5× 451 0.8× 258 0.4× 228 0.5× 47 1.6k
Helen D. Donoghue United Kingdom 25 1.3k 1.2× 975 1.2× 612 1.1× 807 1.4× 467 1.0× 88 2.4k
G. Michael Taylor United Kingdom 25 813 0.7× 716 0.9× 380 0.7× 449 0.8× 298 0.6× 66 1.8k
Lothar Zöller Germany 29 781 0.7× 161 0.2× 281 0.5× 109 0.2× 34 0.1× 58 1.9k
Bart Ferwerda Netherlands 19 278 0.3× 441 0.5× 357 0.6× 78 0.1× 67 0.1× 41 1.5k
Richard Sherburne Canada 23 166 0.2× 265 0.3× 263 0.5× 273 0.5× 53 0.1× 36 1.8k
Marvin J. Allison United States 20 202 0.2× 350 0.4× 180 0.3× 158 0.3× 458 0.9× 81 1.4k
Maria A. Spyrou Germany 22 128 0.1× 114 0.1× 597 1.0× 235 0.4× 207 0.4× 38 1.4k
Gérard Aboudharam France 21 273 0.3× 118 0.1× 698 1.2× 37 0.1× 225 0.5× 60 1.5k
Alessandra Falchi France 24 554 0.5× 475 0.6× 151 0.3× 28 0.0× 42 0.1× 94 1.4k

Countries citing papers authored by Mark Spigelman

Since Specialization
Citations

This map shows the geographic impact of Mark Spigelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Spigelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Spigelman more than expected).

Fields of papers citing papers by Mark Spigelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Spigelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Spigelman. The network helps show where Mark Spigelman may publish in the future.

Co-authorship network of co-authors of Mark Spigelman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Spigelman. A scholar is included among the top collaborators of Mark Spigelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Spigelman. Mark Spigelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Minnikin, David E., Oona Y.-C. Lee, Houdini H.T. Wu, et al.. (2015). Ancient mycobacterial lipids: Key reference biomarkers in charting the evolution of tuberculosis. Tuberculosis. 95. S133–S139. 28 indexed citations
3.
Donoghue, Helen D., Mark Spigelman, Justin O’Grady, et al.. (2015). Ancient DNA analysis – An established technique in charting the evolution of tuberculosis and leprosy. Tuberculosis. 95. S140–S144. 21 indexed citations
4.
Kay, Gemma L., Martin J. Sergeant, Zhemin Zhou, et al.. (2015). Eighteenth-century genomes show that mixed infections were common at time of peak tuberculosis in Europe. Nature Communications. 6(1). 6717–6717. 122 indexed citations
5.
Spigelman, Mark, Helen D. Donoghue, Ziad Abdeen, et al.. (2015). Evolutionary changes in the genome of Mycobacterium tuberculosis and the human genome from 9000 years BP until modern times. Tuberculosis. 95. S145–S149. 15 indexed citations
6.
Szikossy, Ildikó, György Pálfi, Erika Molnár, et al.. (2015). Two positive tuberculosis cases in the late Nigrovits family, 18th century, Vác, Hungary. Tuberculosis. 95. S69–S72. 8 indexed citations
7.
Hershkovitz, Israël, Helen D. Donoghue, David E. Minnikin, et al.. (2015). Tuberculosis origin: The Neolithic scenario. Tuberculosis. 95. S122–S126. 88 indexed citations
8.
Lee, Oona Y.-C., Houdini H.T. Wu, Gurdyal S. Besra, et al.. (2015). Lipid biomarkers provide evolutionary signposts for the oldest known cases of tuberculosis. Tuberculosis. 95. S127–S132. 24 indexed citations
9.
Lee, Oona Y.-C., Houdini H.T. Wu, Helen D. Donoghue, et al.. (2012). Mycobacterium tuberculosis Complex Lipid Virulence Factors Preserved in the 17,000-Year-Old Skeleton of an Extinct Bison, Bison antiquus. PLoS ONE. 7(7). e41923–e41923. 51 indexed citations
10.
Bar‐Gal, Gila Kahila, Myeung Ju Kim, Athalia Klein, et al.. (2012). Tracing hepatitis B virus to the 16th century in a Korean mummy. Hepatology. 56(5). 1671–1680. 75 indexed citations
11.
Matheson, Carney, Kim Vernon, Mark Spigelman, et al.. (2010). Correction: Molecular Exploration of the First-Century Tomb of the Shroud in Akeldama, Jerusalem. PLoS ONE. 5(4). 2 indexed citations
12.
Ereqat, Suheir, Gila Kahila Bar‐Gal, Abedelmajeed Nasereddin, et al.. (2010). Pulmonary tuberculosis in the West Bank, Palestinian Authority: molecular diagnostic approach. Tropical Medicine & International Health. 16(3). 360–367. 5 indexed citations
13.
Matheson, Carney, Kim Vernon, Mark Spigelman, et al.. (2009). Molecular Exploration of the First-Century Tomb of the Shroud in Akeldama, Jerusalem. PLoS ONE. 4(12). e8319–e8319. 32 indexed citations
14.
Hershkovitz, Israël, Helen D. Donoghue, David E. Minnikin, et al.. (2008). Detection and Molecular Characterization of 9000-Year-Old Mycobacterium tuberculosis from a Neolithic Settlement in the Eastern Mediterranean. PLoS ONE. 3(10). e3426–e3426. 283 indexed citations
15.
Lemma, Eshetu, et al.. (2008). Attempts to revive Mycobacterium tuberculosis from 300-year-old human mummies. FEMS Microbiology Letters. 283(1). 54–61. 8 indexed citations
16.
Fletcher, Helen A., Helen D. Donoghue, John Holton, Ildikó Pap, & Mark Spigelman. (2003). Widespread occurrence of Mycobacterium tuberculosis DNA from 18th–19th century Hungarians. American Journal of Physical Anthropology. 120(2). 144–152. 78 indexed citations
17.
Greenblatt, Charles L., et al.. (2002). The Shroud Cave - a unique case study linking a closed loculus, a shroud and ancient mycobacteria. UCL Discovery (University College London). 2 indexed citations
18.
Spigelman, Mark & Helen D. Donoghue. (2001). Brief communication: Unusual pathological condition in the lower extremities of a skeleton from ancient Israel. American Journal of Physical Anthropology. 114(1). 92–93. 25 indexed citations
19.
Ubelaker, Douglas H., et al.. (2000). Skeletal and Molecular Evidence for Tuberculosis in a Forensic Case. UCL Discovery (University College London). 4 indexed citations
20.
Barnes, Ian, John Holton, Dino Vaira, Mark Spigelman, & Mark Thomas. (2000). An assessment of the long-term preservation of the DNA of a bacterial pathogen in ethanol-preserved archival material. The Journal of Pathology. 192(4). 554–559. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026